首页> 外文期刊>The Open Medicinal Chemistry Journal >Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes
【24h】

Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes

机译:天然化合物抑制PPARγ是肥胖和糖尿病的有前途的策略

获取原文
           

摘要

A wide group of natural compounds (flavonoids, stilbenes, neolignans and others) has been identified as Peroxisome Proliferator-Activated Receptor (PPAR) agonists, with a large variety of chemical structure and different activity versus the three PPAR subtypes. These receptors are transcription factors controlling metabolic pathways in the organism, involved in lipid and glucose metabolism, cell differentiation and energy homeostasis. Otherwise, very little is known about natural compounds able to inhibit PPARs. A number of studies demonstrate that PPARγ repression has a beneficial effect in reducing body weight and improving insulin sensitivity, suggesting a potential clinical role in obesity and type 2 diabetes. This review analyzes natural compounds able to repress PPAR activity and their potential use in metabolic disorders.
机译:多种天然化合物(类黄酮,芪,新木脂素等)已被确定为过氧化物酶体增殖物激活受体(PPAR)激动剂,与三种PPAR亚型相比,具有多种化学结构和不同的活性。这些受体是控制生物体内代谢途径的转录因子,参与脂质和葡萄糖代谢,细胞分化和能量稳态。否则,人们对能够抑制PPAR的天然化合物知之甚少。大量研究表明,PPARγ抑制在减轻体重和改善胰岛素敏感性方面具有有益作用,表明在肥胖症和2型糖尿病中可能具有临床作用。这篇综述分析了能够抑制PPAR活性的天然化合物及其在代谢疾病中的潜在用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号